|
2026
|
G/S
|
Pharmaceutical preparations for oncology |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological diseases |
|
|
G/S
|
Ophthalmic surgery devices and instruments for controlled sub-retinal delivery of pharmaceutical,... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cardiovascular, metabolic and renal diseases and... |
|
|
G/S
|
Pharmaceutical preparations for use in neuroscience |
|
|
G/S
|
Pharmaceutical preparations for use in nephropathy. |
|
|
G/S
|
Pharmaceutical preparations for use in nephropathy |
|
|
G/S
|
IC 010: Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devi... |
|
|
G/S
|
pharmaceutical preparations for use in oncology |
|
2025
|
Invention
|
Her2 heterogeneity as a biomarker in cancer.
A method for predicting responsiveness to a HER2-di... |
|
|
Invention
|
Methods and compositions for cancer treatment.
The present application provides methods of treat... |
|
|
Invention
|
Formulations with reduced degradation of polysorbate.
The invention provides methods for making ... |
|
|
Invention
|
System and method for cell-of-origin classification based on interpretable cellular features.
A ... |
|
|
Invention
|
Tie2-binding agents and methods of use.
The invention provides Tie-2 antibodies and fragments th... |
|
|
Invention
|
Cell culture compositions and methods for polypeptide production.
Cell culture media, such as ch... |
|
|
Invention
|
Modified mammalian cells.
The present disclosure relates to methods, cells, and compositions for... |
|
|
Invention
|
Method for the reduction of host cell proteins in affinity chromatography.
The current invention... |
|
|
G/S
|
Downloadable computer software for health and medical data analysis and downloadable computer sof... |
|
|
G/S
|
Platform as a service (PAAS) featuring computer software platforms for early detection of cancer;... |
|
|
Invention
|
Connected machine-learning models with joint training for lesion detection.
Embodiments disclose... |
|
|
Invention
|
Neural network processing of oct data to generate predictions of geographic-atrophy growth rates.... |
|
|
Invention
|
Spatial feature analysis for digital pathology images.
Systems and methods relate to processing ... |
|
|
Invention
|
Density-based immunophenotyping.
Described herein are methods, systems, and programming for dete... |
|
|
Invention
|
Anti-tl1a antibody therapeutic methods.
The present disclosure provides methods and compositions... |
|
|
Invention
|
Three-dimensional molecule generation by denoising voxel grids.
A voxelized representation of an... |
|
|
Invention
|
Three-dimensional molecule generation in latent voxelized space.
A voxelized representation of a... |
|
|
Invention
|
Machine learning enabled analysis of computed tomography and positron emission tomography scans f... |
|
|
Invention
|
Weakly supervised lesion segmentation.
A Generative Adversarial Network (GAN) can be trained, wh... |
|
|
Invention
|
Anti-cd20 antibody formulations. The present application relates to aqueous pharmaceutical formul... |
|
|
Invention
|
Combination treatment of an anti-cd20/anti-cd3 bispecific antibody and chemotherapy.
The present... |
|
|
Invention
|
Combination treatment of an anti-cd20/anti-cd3 bispecific antibody and chemotherapy. The present ... |
|
|
Invention
|
Synthesis of tert-butyl(lr,2s,5s)-2-((s)-l-hydroxyethyl)-2-methyl-3,8- diazabicyclo[3.2.1]octane-... |
|
|
Invention
|
Multicellular representations of single-cell transcriptomics for machine learning enabled patient... |
|
|
Invention
|
Polymeric particles for proximity-based cellular dna-encoded library screening and methods of use... |
|
|
Invention
|
Method of treating cancer using the kras g12d inhibitor gcd-7035. Provided herein are methods of ... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical pre... |
|
|
Invention
|
Heterocyclic compounds for the treatment of neurodegenerative diseases. Provided herein are compo... |
|
|
Invention
|
Lipid nanoparticles for delivery to the cns from systemic administration. in vivoin vivo in the c... |
|
|
Invention
|
Isoform-selective anti-tgf-beta antibodies and methods of use.
The invention provides isoform-se... |
|
|
Invention
|
Diagnostic method of determining the presence of a label-free antibody-antigen complex of interes... |
|
|
Invention
|
Systems and methods for interpretable neural networks for genomic analysis. In one embodiment, a ... |
|
|
Invention
|
Methods for treatment of atopic dermatitis with an anti-tl1a antibody. The present disclosure pro... |
|
|
Invention
|
Methods for treatment of metabolic dysfunction-associated steatohepatitis with an anti-tl1a antib... |
|
|
Invention
|
Pharmacophore-based molecule design by learning on voxel grids. A three-dimensional representatio... |
|
|
Invention
|
Combination therapy of peptide tyrosine-tyrosine (pyy) analogues and glp-1r agonists. The present... |
|
|
Invention
|
Compositions and methods of treating lupus nephritis. inter aliainter alia, methods for depleting... |
|
|
Invention
|
Methods of protein production.
A method of reducing glycation of an amino acid in a protein prod... |
|
|
Invention
|
Formulations with reduced oxidation.
The invention provides formulations comprising a protein in... |
|
|
Invention
|
Methods of treating cancer with an anti-pd-l1 antibody.
The present disclosure relates to method... |
|
|
Invention
|
Tmem175 modulators. Provided herein are TMEM175 modulators having Formula (I) and pharmaceuticall... |
|
|
Invention
|
Unifying foundation model for functional genomics. Machine learning-based methods, systems, and p... |
|
|
Invention
|
Methods for treating cancer using subcutaneous dosing of mosunetuzumab in combination with polatu... |
|
|
Invention
|
Inducible crispr/cas systems with high dynamic range and methods of use. Systems, methods, and co... |
|
|
Invention
|
Process for the preparation of tricyclic pi3k inhibitor compounds and methods for using the same ... |
|
|
Invention
|
Magnetic hydrogel particles and methods of use.
The present invention relates to particles compr... |
|
|
Invention
|
Anti-htra1 antibodies and methods of use thereof.
The present invention provides anti-HtrA1 anti... |
|
|
G/S
|
Educational services, namely, providing presentations in the field of oncology products and disea... |
|
|
Invention
|
Methods of treating cancer using subcutaneous dosing of mosunetuzumab as a monotherapy or in comb... |
|
|
G/S
|
Pharmaceutical preparations, applied subcutaneously, for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in neurological disorders including Alzheimer's |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheim... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
G/S
|
Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devices |
|
|
Invention
|
Bispecific antigen-binding molecules and methods of use.
The present invention provides bispecif... |
|
|
Invention
|
Methods of producing two chain proteins in prokaryotic host cells.
Provided herein are methods a... |
|
|
Invention
|
Methods and compositions for classifying and treating bladder cancer.
The invention provides met... |
|
|
G/S
|
Software products for healthcare, monitoring, screening, assessment, diagnosis, and intervention,... |
|
2024
|
G/S
|
Pharmaceutical preparations for use in immunology |
|
|
G/S
|
Pharmaceutical preparations for use in oncology, neurology and immunology |
|
|
G/S
|
Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neurological diseases |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer. |
|
|
G/S
|
Pharmaceutical preparations for use in ophthalmology |
|
|
G/S
|
Pharmaceutical preparations for use in ophthalmology. |
|
2022
|
Invention
|
Methods and systems for gene alteration prediction from pathology slide images.
Described herein... |
|
|
Invention
|
Pharmaceutical composition comprising anti-pd-l1 antibody used in combination with anti-vegf anti... |
